找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Clinical Metabolomics Applications in Genetic Diseases; Anas M. Abdel Rahman Book 2023 The Editor(s) (if applicable) and The Author(s), un

[复制链接]
楼主: JAR
发表于 2025-3-28 14:51:07 | 显示全部楼层
,Kernwaffen und regionale Stabilität,ethod to provide the theoretical basis for individualized medical treatment. This chapter overviews clinical metabotyping, disease biomarker discovery, and pharmacometabolomics toward personalized medicine, improving drug efficacy. These three approaches enhance the understanding of the disease’s pa
发表于 2025-3-28 19:55:35 | 显示全部楼层
发表于 2025-3-28 23:08:51 | 显示全部楼层
Stephanie L. Moon,Jeffrey Wiluszell as the utilization of nanomaterials as transducers are highlighted. The developments of multiplexed array biosensors for the simultaneous detection of multiple biomarkers and wearable biosensors are discussed as emerging diagnostic tools in metabolomics. The challenges and future perspectives in
发表于 2025-3-29 06:57:07 | 显示全部楼层
发表于 2025-3-29 10:34:42 | 显示全部楼层
Mass Spectrometry-Based Metabolomics for the Clinical Laboratory, of known biomarkers for disease diagnosis and monitoring, general health status evaluation, toxicology, and therapeutic drug monitoring. Although there are exceptions, MS-based assays in the clinical laboratory typically involve the utilization of analyte-specific calibration curves for quantitatio
发表于 2025-3-29 13:09:13 | 显示全部楼层
Metabolomics: A Pipeline for Biomarker Discovery in Genetic Diseases,ertain biological matrix. Metabolomic studies use advanced technologies (nuclear magnetic resonance (NMR) and mass spectrometry (MS)) with bioinformatics to identify and quantify a set of small molecules (such as carbohydrates, nucleic acids, amino acids, and lipids) present in a biological system.
发表于 2025-3-29 17:19:01 | 显示全部楼层
发表于 2025-3-29 22:06:22 | 显示全部楼层
Untargeted Metabolomics in Newborn Screening,disorders at the presymptomatic stage, enabling early disease-modifying intervention that otherwise invariably leads to death or permanent damage if treated at the symptomatic stage. The advent of multiplex high-throughput assays involving chromatography coupled with mass spectroscopy enabled the an
发表于 2025-3-30 02:04:37 | 显示全部楼层
Untargeted Metabolomics, Targeted Care: The Clinical Utilities of Bedside Metabolomics,etabolic pathways of physiologically active cells and tissues, along with an improved resolution of high-throughput screening capabilities, brought forth the clinical metabolome. Clinicians can now take a metabolic snapshot while assessing their patients and receive invaluable information on patholo
发表于 2025-3-30 07:16:16 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-6 04:47
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表